Renshaw L - Search Results

1

Integrative analyses identify modulators of response to neoadjuvant aromatase inhibitors in patients with early breast cancer.

López-Knowles E, Wilkerson PM, Ribas R, Anderson H, Mackay A, Ghazoui Z, Rani A, Osin P, Nerurkar A, Renshaw L, Larionov A, Miller WR, Dixon JM, Reis-Filho JS, Dunbier AK, Martin LA, Dowsett M. López-Knowles E, et al. Among authors: renshaw l. Breast Cancer Res. 2015 Mar 11;17(1):35. doi: 10.1186/s13058-015-0532-0. Breast Cancer Res. 2015. PMID: 25888249 Free PMC article.

2

Lessons from the use of aromatase inhibitors in the neoadjuvant setting.

Dixon JM, Love CD, Renshaw L, Bellamy C, Cameron DA, Miller WR, Leonard RC. Dixon JM, et al. Among authors: renshaw l. Endocr Relat Cancer. 1999 Jun;6(2):227-30. doi: 10.1677/erc.0.0060227. Endocr Relat Cancer. 1999. PMID: 10731113 Review.

3

The effects of neoadjuvant anastrozole (Arimidex) on tumor volume in postmenopausal women with breast cancer: a randomized, double-blind, single-center study.

Dixon JM, Renshaw L, Bellamy C, Stuart M, Hoctin-Boes G, Miller WR. Dixon JM, et al. Among authors: renshaw l. Clin Cancer Res. 2000 Jun;6(6):2229-35. Clin Cancer Res. 2000. PMID: 10873072 Clinical Trial.

4

Neoadjuvant tamoxifen and aromatase inhibitors: comparisons and clinical outcomes.

Dixon JM, Jackson J, Renshaw L, Miller WR. Dixon JM, et al. Among authors: renshaw l. J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):295-9. doi: 10.1016/s0960-0760(03)00370-4. J Steroid Biochem Mol Biol. 2003. PMID: 14623524 Review.

5

Anastrozole demonstrates clinical and biological effectiveness in oestrogen receptor-positive breast cancers, irrespective of the erbB2 status.

Dixon JM, Jackson J, Hills M, Renshaw L, Cameron DA, Anderson TJ, Miller WR, Dowsett M. Dixon JM, et al. Among authors: renshaw l. Eur J Cancer. 2004 Dec;40(18):2742-7. doi: 10.1016/j.ejca.2004.08.025. Eur J Cancer. 2004. PMID: 15571956 Clinical Trial.

6

Surgical issues surrounding use of aromatase inhibitors.

Dixon JM, Renshaw L, Murray J, Macaskill EJ, Young O, Miller WR. Dixon JM, et al. Among authors: renshaw l. J Steroid Biochem Mol Biol. 2005 May;95(1-5):97-103. doi: 10.1016/j.jsbmb.2005.04.024. J Steroid Biochem Mol Biol. 2005. PMID: 16023854

7

Proliferation, steroid receptors and clinical/pathological response in breast cancer treated with letrozole.

Miller WR, White S, Dixon JM, Murray J, Renshaw L, Anderson TJ. Miller WR, et al. Among authors: renshaw l. Br J Cancer. 2006 Apr 10;94(7):1051-6. doi: 10.1038/sj.bjc.6603001. Br J Cancer. 2006. PMID: 16538221 Free PMC article. Clinical Trial.

8

Estrogen-independent proliferation is present in estrogen-receptor HER2-positive primary breast cancer after neoadjuvant letrozole.

Ellis MJ, Tao Y, Young O, White S, Proia AD, Murray J, Renshaw L, Faratian D, Thomas J, Dowsett M, Krause A, Evans DB, Miller WR, Dixon JM. Ellis MJ, et al. Among authors: renshaw l. J Clin Oncol. 2006 Jul 1;24(19):3019-25. doi: 10.1200/JCO.2005.04.3034. Epub 2006 Jun 5. J Clin Oncol. 2006. PMID: 16754938

9

Neoadjuvant use of hormonal therapy in elderly patients with early or locally advanced hormone receptor-positive breast cancer.

Macaskill EJ, Renshaw L, Dixon JM. Macaskill EJ, et al. Among authors: renshaw l. Oncologist. 2006 Nov-Dec;11(10):1081-8. doi: 10.1634/theoncologist.11-10-1081. Oncologist. 2006. PMID: 17110627 Free article. Review.

10

DCIS and aromatase inhibitors.

Dixon JM, Faratian D, White S, Renshaw L, Murray J, Young O, Macaskill EJ, Williams L, Thomas J, Evans DB. Dixon JM, et al. Among authors: renshaw l. J Steroid Biochem Mol Biol. 2007 Aug-Sep;106(1-5):173-9. doi: 10.1016/j.jsbmb.2007.05.015. Epub 2007 May 24. J Steroid Biochem Mol Biol. 2007. PMID: 17604618

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page